Physician profile
Huseyin Arman
NPI 1699395962
$2,379.09
in general payments reported to CMS, 2019-2025
10 companies · $1,609 in 2025
The $1,609 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $770 · 2025: $1,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046 · Education: $221 · Gift: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.55 |
| Education | $221.24 |
| Gift | $112.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $463.51 | 2025 | Onyx Frontier, Resolute Onyx |
| Zoll Circulation INC | $362.50 | 2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Edwards Lifesciences Corporation | $326.50 | 2024-2025 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $280.49 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $263.28 | 2025 | Rotarexs 6 F X 135 Cm |
| Surmodics, INC. | $154.72 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Boston Scientific Corporation | $149.47 | 2025 | Opticross |
| Amgen INC. | $138.82 | 2025 | Repatha |
| Actelion Pharmaceuticals US, INC. | $127.50 | 2025 | Opsumit, Uptravi |
| Abiomed | $112.30 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huseyin Arman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.